BioSpace News Archive

Business

Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain

Haemonetics Corporation announced the appointment of Josep Lluis Llorens as Senior Vice President, Global Manufacturing and Supply Chain, effective August 20, 2018.

August 7, 2018
·
2 min read
Deals

Bio-Techne Declares Dividend Payable August 31, 2018

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2018.

August 7, 2018
·
1 min read
Drug Development

BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today positive results from the lead-in period of the GENESIS trial.

August 7, 2018
·
7 min read
Business

Bio-Techne Releases Fourth Quarter Fiscal 2018 Results

Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2018.

August 7, 2018
·
28 min read
Policy

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

Covers ApoGraft’s uses, methods and devices in stem cell selection for conditions including GvHD

August 7, 2018
·
5 min read
Drug Development

NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study

NanoViricides, Inc. (NYSE Amer: NNVC) (the “Company”) reports that its anti-Shingles drug candidates were effective in ameliorating pain sensations in an animal model of abnormal pain.

August 7, 2018
·
6 min read
Business

RXi Pharmaceuticals to Webcast Second Quarter 2018 Financial Results on Tuesday, August 14, 2018

RXi Pharmaceuticals Corporation announced that it will report its financial results for the second quarter ended June 30, 2018, and provide a business update on Tuesday, August 14, 2018 after the close of the U.S. financial markets.

August 7, 2018
·
3 min read
Business

Realm Therapeutics to Report First Half 2018 Financial Results

Realm’s management team will host a conference call and audio webcast at 9:00 a.m. ET / 2:00 p.m. BST on Tuesday, August 14, 2018 to discuss the financial results and recent operational highlights.

August 7, 2018
·
3 min read
Business

Rallybio Welcomes Laura Ekas, PhD and Eric Watsky, MD, Further Expanding Rallybio’s Drug Acquisition and Development Capabilities

Dr. Ekas and Dr. Watsky now join Rallybio’s co-founders and other veteran industry executives in advancing Rallybio’s mission to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders.

August 7, 2018
·
4 min read
Business

Eagle Pharmaceuticals, Inc. Reports Second Quarter 2018 Results

Q2 2018 net income was $0.18 per basic and $0.17 per diluted share and adjusted non-GAAP net income of $0.99 per basic and $0.95 per diluted share

August 7, 2018
·
19 min read